Inhaled Corticosteroid Market

Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use. Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in the development of new inhaler corticosteroid devices.
Inhaled Corticosteroid Market contains market size and forecasts of Inhaled Corticosteroid in global, including the following market information:
Global Inhaled Corticosteroid Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Inhaled Corticosteroid Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Inhaled Corticosteroid companies in 2021 (%)
The global Inhaled Corticosteroid market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Beclomethasone Dipropionate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Inhaled Corticosteroid include Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca and Teijin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Inhaled Corticosteroid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inhaled Corticosteroid Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Inhaled Corticosteroid Market Segment Percentages, by Type, 2021 (%)
Beclomethasone Dipropionate
Budesonide
Fluticasone Inhaler Powder
Mometasone
Others
Global Inhaled Corticosteroid Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Inhaled Corticosteroid Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Respiratory Care Centers
Others
Global Inhaled Corticosteroid Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Inhaled Corticosteroid Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inhaled Corticosteroid revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Inhaled Corticosteroid revenues share in global market, 2021 (%)
Key companies Inhaled Corticosteroid sales in global market, 2017-2022 (Estimated), (MT)
Key companies Inhaled Corticosteroid sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson and Johnson
GSK
AstraZeneca
Teijin
Glaxo's Advair
Amgen
Kos Pharmaceutical
Teva Pharmaceutical